These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7843951)

  • 1. Treatment of childhood headache with dihydroergotamine mesylate.
    Linder SL
    Headache; 1994; 34(10):578-80. PubMed ID: 7843951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache.
    Edwards KR; Norton J; Behnke M
    Headache; 2001; 41(10):976-80. PubMed ID: 11903525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with patient administered subcutaneous dihydroergotamine mesylate in refractory headaches.
    Klapper JA; Stanton J
    Headache; 1992 Jan; 32(1):21-3. PubMed ID: 1372884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of an Intravenous Dihydroergotamine Protocol for Refractory Migraine in Children.
    Theroux LM; Cappa R; Mendoza A; Mallawaarachchi I; Samanta D; Goodkin HP
    Headache; 2020 Sep; 60(8):1653-1663. PubMed ID: 32853454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache.
    Swidan SZ; Lake AE; Saper JR
    Curr Pain Headache Rep; 2005 Feb; 9(1):65-70. PubMed ID: 15625028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches.
    Klapper JA; Stanton JS
    Headache; 1991 Sep; 31(8):523-4. PubMed ID: 1960056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroergotamine infusion for pediatric refractory headache: A retrospective chart review.
    Srouji R; Schenkel SR; Forbes P; Cahill JE
    Headache; 2021 May; 61(5):777-789. PubMed ID: 34105158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous intravenous dihydroergotamine in the treatment of intractable headache.
    Ford RG; Ford KT
    Headache; 1997 Mar; 37(3):129-36. PubMed ID: 9100396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive intravenous DHE in the treatment of refractory headache.
    Silberstein SD; Schulman EA; Hopkins MM
    Headache; 1990 May; 30(6):334-9. PubMed ID: 2370132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient repetitive intravenous dihydroergotamine.
    Robbins L; Remmes A
    Headache; 1992 Oct; 32(9):455-8. PubMed ID: 1446990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
    Robbins NM; Ito H; Scheinman MM; Goadsby PJ
    Neurology; 2016 Dec; 87(24):2522-2526. PubMed ID: 27837002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of dihydroergotamine in patients with postconcussion syndrome.
    McBeath JG; Nanda A
    Headache; 1994 Mar; 34(3):148-51. PubMed ID: 8200788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing Outpatient Dihydroergotamine Infusion With Interdisciplinary Care to Treat Refractory Pediatric Migraine: Preliminary Outcomes From the Comprehensive Aggressive Migraine Protocol ("CAMP").
    Connelly M; Sekhon S; Stephens D; Boorigie M; Bickel J
    Headache; 2020 Jan; 60(1):101-109. PubMed ID: 31626335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks].
    Pradalier A; Guérard des Lauriers A; Scheck F; Peraudeau P; Lacoste JP; Cajfinger F
    Pathol Biol (Paris); 1995 Nov; 43(9):806-13. PubMed ID: 8746103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroergotamine and metoclopramide in the treatment of organic headache.
    Gross DW; Donat JR; Boyle CA
    Headache; 1995; 35(10):637-8. PubMed ID: 8550366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and Cost of Inpatient Hospitalization for Intravenous Dihydroergotamine Treatment of Refractory Pediatric Headache.
    Nelson GR; Bale JF; Kerr LM
    Pediatr Neurol; 2017 Jan; 66():76-81. PubMed ID: 27847180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroergotamine nasal spray for relief of refractory headache: a retrospective chart review.
    Fisher M; Gosy EJ; Heary B; Shaw D
    Curr Med Res Opin; 2007 Apr; 23(4):751-5. PubMed ID: 17407631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-patient treatment of chronic daily headache using dihydroergotamine: a long-term follow-up study.
    Pringsheim T; Howse D
    Can J Neurol Sci; 1998 May; 25(2):146-50. PubMed ID: 9604137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache.
    Belgrade MJ; Ling LJ; Schleevogt MB; Ettinger MG; Ruiz E
    Neurology; 1989 Apr; 39(4):590-2. PubMed ID: 2648190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where is dihydroergotamine mesylate in the changing landscape of migraine therapy?
    Morren JA; Galvez-Jimenez N
    Expert Opin Pharmacother; 2010 Dec; 11(18):3085-93. PubMed ID: 21080856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.